233 related articles for article (PubMed ID: 2888633)
1. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
[TBL] [Abstract][Full Text] [Related]
2. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
Kapetanovic IM; Kupferberg HJ
Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.
Kapetanovic IM; Kupferberg HJ
Drug Metab Dispos; 1985; 13(4):430-7. PubMed ID: 2863106
[TBL] [Abstract][Full Text] [Related]
4. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
Atal CK; Dubey RK; Singh J
J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
[TBL] [Abstract][Full Text] [Related]
5. Induction and inhibition of rat hepatic drug metabolism by N-substituted imidazole drugs.
Ritter JK; Franklin MR
Drug Metab Dispos; 1987; 15(3):335-43. PubMed ID: 2886308
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
Kaul KL; Novak RF
J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
[TBL] [Abstract][Full Text] [Related]
7. Disposition of nafimidone in rats.
Graham DJ; Hama KM; Smith SA; Kurz L; Chaplin MD; Hall DJ
Drug Metab Dispos; 1987; 15(4):565-70. PubMed ID: 2888632
[TBL] [Abstract][Full Text] [Related]
8. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
Augustine JA; Zemaitis MA
Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary lipid on drug-metabolizing enzymes.
Wade AE; Norred WP
Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
Budris DM; Yim GK; Schnell RC
J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the anticonvulsants, denzimol and nafimidone, with liver cytochrome P450 in the rat.
Salmona M; Conti I; Testa R; Fracasso C; Caccia S
J Pharm Pharmacol; 1988 Jan; 40(1):17-21. PubMed ID: 2896768
[TBL] [Abstract][Full Text] [Related]
12. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
Wade AE; Evans JS; Holmes D; Baker MT
Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
[TBL] [Abstract][Full Text] [Related]
13. The effect of etomidate on rabbit liver microsomal drug metabolism in vitro.
Horai Y; White PF; Trevor AJ
Drug Metab Dispos; 1985; 13(3):364-7. PubMed ID: 2861997
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and spectral studies of type I and type II compounds with rat hepatic microsomes in the presence of the major metabolite of diphenylhydantoin.
Stavchansky SA; Kostenbauder HB; Lubawy WC
Drug Metab Dispos; 1975; 3(6):557-64. PubMed ID: 1233
[TBL] [Abstract][Full Text] [Related]
15. Clotrimazole induction of cytochrome P-450: dose-differentiated isozyme induction.
Ritter JK; Franklin MR
Mol Pharmacol; 1987 Feb; 31(2):135-9. PubMed ID: 3100941
[TBL] [Abstract][Full Text] [Related]
16. Drug metabolism in a reconstituted system by diabetes-dependent hepatic cytochrome P-450.
Past MR; Cook DE
Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):81-90. PubMed ID: 6812187
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
Robertson DW; Krushinski JH; Beedle EE; Leander JD; Wong DT; Rathbun RC
J Med Chem; 1986 Sep; 29(9):1577-86. PubMed ID: 3746810
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
19. The effect of fleroxacin on hepatic drug metabolism in the rat.
Grech-Bélanger O; Francoeur J; Le Bel M
Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):121-33. PubMed ID: 2501838
[TBL] [Abstract][Full Text] [Related]
20. Interaction between selenium and phenobarbital on drug response and hepatic microsomal enzyme activity in the male rat.
Schnell RC; Early JL
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):181-4. PubMed ID: 7291724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
